Highbridge Capital Management’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Highbridge Capital Management’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Hold	0	–	–	–	303
2024 Q2	–	Hold	0	–	–	–	281
2024 Q1	–	Hold	0	–	–	–	254
2023 Q4	–	Hold	0	–	–	–	297
2023 Q3	–	Hold	0	–	–	–	347
2023 Q2	–	Hold	0	–	–	–	337
2023 Q1	–	Hold	0	–	–	–	264

Other funds holding LSBPW

Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return

Valliance Asset Management Central, Hong Kong $864M AUM 906.77% 1-Year Est. Return

BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Ovata Capital Management Hong Kong $1.33B AUM 5.69% 1-Year Est. Return

Q Global Advisors Fort Worth, Texas $157M AUM 29.28% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return